BioMarin Pharmaceutical Competitors and Similar CompaniesClear all
BioMarin Pharmaceutical's competitors and similar companies include CSL Behring and UCB.
 BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 1997 | Founding Date 1904 | Founding Date 1928 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 3,0015% increase | Employees 7,5692% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) 13.3 b | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $717.4m (FY, 2025) | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $348.9m (FY, 2025) | Net income N/A | Net income €1.6b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 100 (Dec, 2020) | Countries 35 (FY, 2019) |
Patent Applications | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) | Patent Applications N/A |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company